| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2008PNAS..10516224L |
| P356 | DOI | 10.1073/PNAS.0808041105 |
| P932 | PMC publication ID | 2571022 |
| P698 | PubMed publication ID | 18852474 |
| P5875 | ResearchGate publication ID | 23314657 |
| P50 | author | James Agnew | Q6128409 |
| Len A. Pennacchio | Q6521643 | ||
| Victor Velculescu | Q7926425 | ||
| Bert Vogelstein | Q827502 | ||
| Kenneth W. Kinzler | Q28031580 | ||
| Tobias Sjöblom | Q88538496 | ||
| Sanford D Markowitz | Q96071153 | ||
| Rebecca J Leary | Q114439503 | ||
| Levy Kopelovich | Q116781885 | ||
| Jordan M Cummins | Q116781891 | ||
| Simina M. Boca | Q37393163 | ||
| Siân Jones | Q42696646 | ||
| Jimmy Cheng-Ho Lin | Q87692837 | ||
| Laura D Wood | Q87796159 | ||
| P2093 | author name string | Tian-Li Wang | |
| Dawn Dawson | |||
| Joseph Willis | |||
| Ramon Parsons | |||
| Yuri Nikolsky | |||
| Nick Papadopoulos | |||
| Tatiana Nikolskaya | |||
| D Williams Parsons | |||
| Giovanni Parmigiani | |||
| Ben-Ho Park | |||
| P2860 | cites work | Digital karyotyping | Q22066241 |
| Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
| Characterizing the cancer genome in lung adenocarcinoma | Q24649926 | ||
| End-sequence profiling: sequence-based analysis of aberrant genomes | Q24670275 | ||
| Architectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolution | Q24676904 | ||
| Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene | Q27860693 | ||
| PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer | Q27860985 | ||
| The consensus coding sequences of human breast and colorectal cancers | Q27861035 | ||
| The genomic landscapes of human breast and colorectal cancers | Q27861078 | ||
| A cell cycle regulator potentially involved in genesis of many tumor types | Q28251933 | ||
| Role of the p16 tumor suppressor gene in cancer | Q28265169 | ||
| A high-resolution survey of deletion polymorphism in the human genome | Q94465012 | ||
| Large-scale copy number polymorphism in the human genome | Q28273726 | ||
| Cancer genes and the pathways they control | Q28275089 | ||
| Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers | Q28306997 | ||
| Mutational analysis of gene families in human cancer | Q29038888 | ||
| Patterns of somatic mutation in human cancer genomes | Q29547841 | ||
| Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia | Q29614324 | ||
| DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 | Q29616726 | ||
| Pathway mapping tools for analysis of high content data | Q31061740 | ||
| Digital karyotyping. | Q33294343 | ||
| Diabetes and obesity: the twin epidemics | Q34482313 | ||
| High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping | Q35012994 | ||
| Genetic alterations in cancer as a result of breakage at fragile sites | Q35085395 | ||
| Targeting the absence: homozygous DNA deletions as immutable signposts for cancer therapy | Q36002501 | ||
| Array comparative genomic hybridization and its applications in cancer | Q36141621 | ||
| Chromosomal breakpoints in primary colon cancer cluster at sites of structural variants in the genome | Q36509335 | ||
| Comparative lesion sequencing provides insights into tumor evolution | Q36670136 | ||
| Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays | Q36802303 | ||
| Emerging DNA sequencing technologies for human genomic medicine | Q37206437 | ||
| PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer | Q39992398 | ||
| Homozygous deletion scanning of the lung cancer genome at a 100-kb resolution | Q40098447 | ||
| Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis | Q40402337 | ||
| Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays. | Q42806564 | ||
| Whole-genome genotyping with the single-base extension assay | Q46105256 | ||
| Three classes of genes mutated in colorectal cancers with chromosomal instability | Q47652214 | ||
| Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line | Q53564566 | ||
| The power of riboswitches. | Q54449665 | ||
| Mapping the cancer genome. Pinpointing the genes involved in cancer will help chart a new course across the complex landscape of human malignancies. | Q55043541 | ||
| Frequency of homozygous deletion at p16/CDKN2 in primary human tumours | Q71721193 | ||
| Amplification and overexpression of topoisomerase IIalpha predict response to anthracycline-based therapy in locally advanced breast cancer | Q77924534 | ||
| High-resolution genomic and expression analyses of copy number alterations in breast tumors | Q80856831 | ||
| Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401 | Q83305244 | ||
| P433 | issue | 42 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | homozygosity | Q114049690 |
| P304 | page(s) | 16224-9 | |
| P577 | publication date | 2008-10-21 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers | |
| P478 | volume | 105 |
| Q92286756 | A Review on Dietary Intervention in Obesity Associated Colon Cancer |
| Q24614467 | A decade of exploring the cancer epigenome — biological and translational implications |
| Q39485860 | A model of early human embryonic stem cell differentiation reveals inter- and intracellular changes on transition to squamous epithelium. |
| Q33859531 | A pathway-based classification of human breast cancer. |
| Q42120343 | A systems approach to analysis of molecular complexity in breast cancer |
| Q34186488 | Active site mutations in mammalian DNA polymerase delta alter accuracy and replication fork progression |
| Q28087050 | Adhesion in mammary development: novel roles for E-cadherin in individual and collective cell migration |
| Q35123202 | Advancing a clinically relevant perspective of the clonal nature of cancer |
| Q92493872 | Amplification of the EGFR and CCND1 Are Coordinated and Play Important Roles in the Progression of Oral Squamous Cell Carcinomas |
| Q33711499 | An integrated analysis of molecular aberrations in NCI-60 cell lines |
| Q33901638 | Analysis of the mitogen-activated protein kinase kinase 4 (MAP2K4) tumor suppressor gene in ovarian cancer |
| Q27009170 | Animal models of colorectal cancer |
| Q34001641 | Animal models of gastrointestinal and liver diseases. New mouse models for studying dietary prevention of colorectal cancer |
| Q33513312 | Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-down |
| Q36595749 | Applying ecological and evolutionary theory to cancer: a long and winding road |
| Q53383644 | Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis |
| Q30252881 | Aromatase expression in atypical ductal hyperplasia in women |
| Q33532647 | Automated network analysis identifies core pathways in glioblastoma |
| Q34207688 | Breast cancer genomes--form and function |
| Q38406502 | CGH arrays compared for DNA isolated from formalin-fixed, paraffin-embedded material |
| Q24607064 | CaSNP: a database for interrogating copy number alterations of cancer genome from SNP array data |
| Q42962720 | Cancer detection using whole-genome sequencing of cell free DNA. |
| Q24650086 | Cancer systems biology: a network modeling perspective |
| Q37662148 | Carcinogen 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis is accelerated in Smad3 heterozygous mice compared to Smad3 wild type mice |
| Q43378663 | Cat Mammary Tumors: Genetic Models for the Human Counterpart |
| Q36296457 | Challenges in Identifying Candidate Amplification Targets in Human Cancers: Chromosome 8q21 as a Case Study |
| Q35088103 | Chromosomal copy number aberrations in colorectal metastases resemble their primary counterparts and differences are typically non-recurrent |
| Q36566531 | Clonal evolution and therapeutic resistance in solid tumors |
| Q52620979 | Colorectal adenoma to carcinoma progression is accompanied by changes in gene expression associated with ageing, chromosomal instability, and fatty acid metabolism |
| Q34207776 | Colorectal cancer with liver metastases: neoadjuvant chemotherapy, surgical resection first or palliation alone? |
| Q39117990 | Combined analysis of copy number alterations by single-nucleotide polymorphism array and MYC status in non-metastatic breast cancer patients: comparison according to the circulating tumor cell status. |
| Q104795307 | Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts |
| Q36637287 | Context is everything for dependence receptors in colorectal cancer |
| Q34479642 | Controlled somatic and germline copy number variation in the mouse model |
| Q92542726 | Copy Number Variation Pattern for Discriminating MACROD2 States of Colorectal Cancer Subtypes |
| Q37295121 | Copy number variation has little impact on bead-array-based measures of DNA methylation. |
| Q41888157 | Correlation between oncogenic mutations and parameter sensitivity of the apoptosis pathway model |
| Q37657891 | DNA secondary structures and epigenetic determinants of cancer genome evolution |
| Q34066311 | Deciphering causal and statistical relations of molecular aberrations and gene expressions in NCI-60 cell lines |
| Q38265995 | Deciphering oncogenic drivers: from single genes to integrated pathways |
| Q21195898 | Deficient expression of DNA repair enzymes in early progression to sporadic colon cancer |
| Q61757455 | Detection limits of DNA copy number alterations in heterogeneous cell populations |
| Q28280303 | Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing |
| Q34371069 | Detection of genomic aberrations in molecularly defined Burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis |
| Q34519922 | Detection of human tumor cells by amplicon fusion site polymerase chain reaction (AFS-PCR) |
| Q28278819 | Development of personalized tumor biomarkers using massively parallel sequencing |
| Q36392698 | Developmental genes significantly afflicted by aberrant promoter methylation and somatic mutation predict overall survival of late-stage colorectal cancer |
| Q46942532 | Dietary folate suppresses DMH-induced colon carcinogenesis in a rat model and affects DMH-induced expression of four DNA repair enzymes |
| Q37377920 | Dissecting the gray zone between follicular lymphoma and marginal zone lymphoma using morphological and genetic features |
| Q34671454 | Distinguishing between driver and passenger mutations in individual cancer genomes by network enrichment analysis |
| Q30525532 | ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium |
| Q24810389 | ERBB2 in cat mammary neoplasias disclosed a positive correlation between RNA and protein low expression levels: a model for erbB-2 negative human breast cancer |
| Q35640263 | Elevated PI3K signaling drives multiple Breast Cancer subtypes |
| Q34175129 | Emergence of single-molecule sequencing and potential for molecular diagnostic applications |
| Q28084849 | Epigenetic regulation of the intestinal epithelium |
| Q52832002 | Establishment and genetic characterization of an immortal tumor cell line derived from intestinal-type sinonasal adenocarcinoma |
| Q28303776 | Fields and field cancerization: the preneoplastic origins of cancer: asymptomatic hyperplastic fields are precursors of neoplasia, and their progression to tumors can be tracked by saturation density in culture |
| Q39276579 | Focal aberrations indicate EYA2 and hsa-miR-375 as oncogene and tumor suppressor in cervical carcinogenesis |
| Q34797092 | Focal chromosomal copy number aberrations identify CMTM8 and GPR177 as new candidate driver genes in osteosarcoma |
| Q41691639 | FocalCall: An R Package for the Annotation of Focal Copy Number Aberrations |
| Q35722912 | Focus on 16p13.3 Locus in Colon Cancer |
| Q39145987 | Functional exploration of colorectal cancer genomes using Drosophila |
| Q33898189 | Future of personalized medicine in oncology: a systems biology approach |
| Q38527414 | Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy. |
| Q38370393 | Gender differences in colorectal cancer survival: A meta-analysis. |
| Q39752244 | Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma. |
| Q24658185 | Genetic mutations associated with cigarette smoking in pancreatic cancer |
| Q36973612 | Genome evolution during progression to breast cancer |
| Q35841605 | Genome-wide Methylation Analysis Identifies Genes Specific to Breast Cancer Hormone Receptor Status and Risk of Recurrence |
| Q35600924 | Genome-wide expression and copy number analysis identifies driver genes in gingivobuccal cancers |
| Q33534919 | Genome-wide gene copy number and expression analysis of primary gastric tumors and gastric cancer cell lines |
| Q34354428 | Genome-wide identification of significant aberrations in cancer genome. |
| Q37276772 | Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia |
| Q37363928 | Genomic and proteomic biomarkers for cancer: a multitude of opportunities. |
| Q34568317 | Genomic landscape of metastatic colorectal cancer |
| Q91993896 | Hierarchical discovery of large-scale and focal copy number alterations in low-coverage cancer genomes |
| Q86783977 | High resolution SNP array profiling identifies variability in retinoblastoma genome stability |
| Q37065678 | How Genetically Engineered Mouse Tumor Models Provide Insights Into Human Cancers |
| Q33554201 | Human cancers express mutator phenotypes: origin, consequences and targeting |
| Q34358106 | IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemia |
| Q36879136 | IRS2 is a candidate driver oncogene on 13q34 in colorectal cancer. |
| Q53407519 | IRS2 mutations linked to invasion in pleomorphic invasive lobular carcinoma |
| Q28741689 | Identification of Tumor Suppressors and Oncogenes from Genomic and Epigenetic Features in Ovarian Cancer |
| Q35075615 | Identification of candidate driver genes in common focal chromosomal aberrations of microsatellite stable colorectal cancer |
| Q55002474 | Identification of different mutational profiles in cancers arising in specific colon segments by next generation sequencing. |
| Q98177113 | Identification of relevant genetic alterations in cancer using topological data analysis |
| Q36629870 | In Silico Discovery of Mitosis Regulation Networks Associated with Early Distant Metastases in Estrogen Receptor Positive Breast Cancers |
| Q37442868 | Insights into gliomagenesis: systems biology unravels key pathways |
| Q59329764 | Instantaneous mutation rate in cancer initiation and progression |
| Q93372382 | Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines |
| Q34026325 | Integrated analyses of copy number variations and gene expression in lung adenocarcinoma |
| Q34054123 | Integrating diverse genomic data using gene sets |
| Q28383312 | Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast |
| Q37216672 | Integrative genomic approaches to understanding cancer. |
| Q34979737 | KAP1 promotes proliferation and metastatic progression of breast cancer cells |
| Q36393067 | Key signaling nodes in mammary gland development and cancer: Smad signal integration in epithelial cell plasticity |
| Q33988970 | Lack of genomic heterogeneity at high-resolution aCGH between primary breast cancers and their paired lymph node metastases |
| Q46129242 | Large chromosome deletions, duplications, and gene conversion events accumulate with age in normal human colon crypts |
| Q36353705 | Long noncoding RNAs in cancer: from function to translation |
| Q28743550 | M402, a Novel Heparan Sulfate Mimetic, Targets Multiple Pathways Implicated in Tumor Progression and Metastasis |
| Q37588178 | MLH1-silenced and non-silenced subgroups of hypermutated colorectal carcinomas have distinct mutational landscapes |
| Q33579388 | Mass spectrometry MALDI imaging of colon cancer biomarkers: a new diagnostic paradigm |
| Q35612950 | Mode of action and pharmacogenomic biomarkers for exceptional responders to didemnin B |
| Q82521439 | Molecular Genetics of Colorectal Cancer |
| Q34013823 | Molecular genetic analysis of 103 sporadic colorectal tumours in Czech patients. |
| Q24617331 | Molecular origins of cancer: Molecular basis of colorectal cancer |
| Q28078345 | Molecular pathogenesis of sporadic colorectal cancers |
| Q37139174 | Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention |
| Q39979970 | Musings on genome medicine: cancer genetics and the promise of effective treatment |
| Q39345007 | Mutational Signatures in Breast Cancer: The Problem at the DNA Level |
| Q36031579 | Mutational heterogeneity in human cancers: origin and consequences. |
| Q34388520 | Mutational signatures of de-differentiation in functional non-coding regions of melanoma genomes |
| Q33354547 | Myeloid Neoplasias: What Molecular Analyses Are Telling Us |
| Q37853198 | New targeted therapies for gastric cancer |
| Q40427450 | Next Generation Sequencing of Circulating Cell-Free DNA for Evaluating Mutations and Gene Amplification in Metastatic Breast Cancer |
| Q34634272 | Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity |
| Q35368205 | Our changing view of the genomic landscape of cancer |
| Q27022312 | Peptide-based vaccines for cancer therapy |
| Q38235205 | Personalized medicine approaches for colon cancer driven by genomics and systems biology: OncoTrack |
| Q37776547 | Personalized therapies in the cancer "omics" era |
| Q37173925 | Polyclonal immune responses to antigens associated with cancer signaling pathways and new strategies to enhance cancer vaccines |
| Q35739529 | Potential role of a navigator gene NAV3 in colorectal cancer. |
| Q37695981 | Preprocessing and downstream analysis of microarray DNA copy number profiles |
| Q55307845 | Prognostic value of microRNAs in colorectal cancer: a meta-analysis. |
| Q37701523 | RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR. |
| Q37689373 | RNA editing in RHOQ promotes invasion potential in colorectal cancer |
| Q34048144 | RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells. |
| Q37156034 | Replication stress induces genome-wide copy number changes in human cells that resemble polymorphic and pathogenic variants |
| Q82313928 | Search for new genes involved in breast tumorigenesis by "Omics" analysis |
| Q35865954 | Sequence variants and haplotype analysis of cat ERBB2 gene: a survey on spontaneous cat mammary neoplastic and non-neoplastic lesions. |
| Q39758487 | Smad3 protein levels are modulated by Ras activity and during the cell cycle to dictate transforming growth factor-beta responses |
| Q33981293 | Somatic Genetics Empowers the Mouse for Modeling and Interrogating Developmental and Disease Processes |
| Q35825951 | Somatic mutations in the notch, NF‐KB, PIK3CA, and hedgehog pathways in human breast cancers |
| Q39290041 | Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion. |
| Q37699356 | Stem cells of the breast and cancer therapy |
| Q26766390 | Strategies for Integrated Analysis of Genetic, Epigenetic, and Gene Expression Variation in Cancer: Addressing the Challenges |
| Q35167227 | Systematic detection of putative tumor suppressor genes through the combined use of exome and transcriptome sequencing |
| Q39555246 | Systems‐level analysis of clinically different phenotypes of juvenile nasopharyngeal angiofibromas |
| Q34735416 | Targeted sequencing of cancer-related genes in colorectal cancer using next-generation sequencing |
| Q92218154 | Targeted short read sequencing and assembly of re-arrangements and candidate gene loci provide megabase diplotypes |
| Q53201323 | Targeting the epigenome for treatment of cancer |
| Q37208752 | The breast cancer somatic 'muta-ome': tackling the complexity |
| Q34570062 | The chromosomal instability pathway in colon cancer |
| Q28301196 | The genetic landscape of the childhood cancer medulloblastoma |
| Q29614700 | The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups |
| Q36930106 | The genomic landscape of response to EGFR blockade in colorectal cancer. |
| Q41829072 | The human cell surfaceome of breast tumors |
| Q37120242 | The importance of phase information for human genomics |
| Q34143477 | The origins of cancer robustness and evolvability. |
| Q33829460 | The ovarian cancer oncobiome |
| Q39427742 | The phosphoinositide 3-kinase inhibitor LY294002, decreases aminoacyl-tRNA synthetases, chaperones and glycolytic enzymes in human HT-29 colorectal cancer cells |
| Q83815683 | The rewards and challenges of array-based karyotyping for clinical oncology applications |
| Q39344496 | Transforming growth factor β inhibits bone morphogenetic protein-induced transcription through novel phosphorylated Smad1/5-Smad3 complexes |
| Q50104779 | Transforming growth factor-β in stem cells and tissue homeostasis |
| Q36495792 | Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer |
| Q92539420 | Variational Autoencoders for Cancer Data Integration: Design Principles and Computational Practice |
| Q24653972 | Whole-genome cancer analysis as an approach to deeper understanding of tumour biology |
| Q33869648 | Widespread Hypomethylation Occurs Early and Synergizes with Gene Amplification during Esophageal Carcinogenesis |
| Q54206333 | Wingless/Wnt Signaling in Intestinal Development, Homeostasis, Regeneration and Tumorigenesis: A Drosophila Perspective |
Search more.